Home › Trial NCT03338777
Suicide Plus Immune Gene Therapy for Advanced Melanoma
- Trial IDNCT03338777
- StatusTerminated
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorHospital Italiano de Buenos Aires
- Enrollment4
- Start date2020-02-20
- ConditionsMelanoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.